ABOS logo

Acumen Pharmaceuticals (ABOS)

Profile

Full Name

Acumen Pharmaceuticals, Inc.

Ticker Symbol

ABOS

Exchange

NASDAQ

Country

United States

IPO

July 1, 2021

Indexes

Not included

Employees

61

Key Details

Price

$1.05(-4.55%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.71(-58.33% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 28, 25 UBS
Buy
Mar 28, 25 HC Wainwright & Co.
Buy
Nov 13, 24 HC Wainwright & Co.
Buy
Oct 3, 24 HC Wainwright & Co.
Buy
Aug 15, 24 UBS
Buy
Aug 14, 24 HC Wainwright & Co.
Buy
Jul 25, 24 Citigroup
Buy
May 15, 24 HC Wainwright & Co.
Buy
Mar 31, 24 UBS
Buy
Mar 27, 24 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for Acumen Pharmaceuticals?
  • Does Acumen Pharmaceuticals pay dividends?
  • What sector is Acumen Pharmaceuticals in?
  • What industry is Acumen Pharmaceuticals in?
  • What country is Acumen Pharmaceuticals based in?
  • When did Acumen Pharmaceuticals go public?
  • Is Acumen Pharmaceuticals in the S&P 500?
  • Is Acumen Pharmaceuticals in the NASDAQ 100?
  • Is Acumen Pharmaceuticals in the Dow Jones?
  • When was Acumen Pharmaceuticals's last earnings report?
  • When does Acumen Pharmaceuticals report earnings?
  • Should I buy Acumen Pharmaceuticals stock now?

What is the ticker symbol for Acumen Pharmaceuticals?

The ticker symbol for Acumen Pharmaceuticals is NASDAQ:ABOS

Does Acumen Pharmaceuticals pay dividends?

No, Acumen Pharmaceuticals does not pay dividends

What sector is Acumen Pharmaceuticals in?

Acumen Pharmaceuticals is in the Healthcare sector

What industry is Acumen Pharmaceuticals in?

Acumen Pharmaceuticals is in the Biotechnology industry

What country is Acumen Pharmaceuticals based in?

Acumen Pharmaceuticals is headquartered in United States

When did Acumen Pharmaceuticals go public?

Acumen Pharmaceuticals's initial public offering (IPO) was on July 1, 2021

Is Acumen Pharmaceuticals in the S&P 500?

No, Acumen Pharmaceuticals is not included in the S&P 500 index

Is Acumen Pharmaceuticals in the NASDAQ 100?

No, Acumen Pharmaceuticals is not included in the NASDAQ 100 index

Is Acumen Pharmaceuticals in the Dow Jones?

No, Acumen Pharmaceuticals is not included in the Dow Jones index

When was Acumen Pharmaceuticals's last earnings report?

Acumen Pharmaceuticals's most recent earnings report was on Mar 27, 2025

When does Acumen Pharmaceuticals report earnings?

The next expected earnings date for Acumen Pharmaceuticals is May 14, 2025

Should I buy Acumen Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page